BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14619463)

  • 1. [Analysis of 5-year survival among breast cancer patients with malignant pleural effusion receiving intrapleural OK-432 followed by adoptive transfer with cultured effusion lymphocytes].
    Kan N
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1559-61. PubMed ID: 14619463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intrapleural administration with OK-432 and cultured autologous pleural effusion lymphocytes for breast cancer patients with malignant pleural effusions: analysis of 84 patients over a 14-year period].
    Kan N
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1796-800. PubMed ID: 10560397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
    Morisaki T; Matsumoto K; Kuroki H; Kubo M; Baba E; Onishi H; Tasaki A; Nakamura M; Inaba S; Katano M
    Anticancer Res; 2003; 23(6a):4459-65. PubMed ID: 14666734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusion.
    Hori T; Mise K; Kan N; Okino T; Satoh K; Yamasaki S; Teramura Y; Harada T; Ohgaki K; Kodama H
    Biotherapy; 1992; 5(1):21-9. PubMed ID: 1389900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intrapleural treatment of breast cancer patients with pleural effusions: an analysis of 13 institutes in Kyoto and Shiga Prefectures. Kyoto and Shiga Breast Cancer Study Group].
    Kan N; Kodama H; Hori T; Takenaka A; Yasumura T; Kato H; Ogawa H; Ohsumi K; Kudo N; Mukaihara S
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1632-5. PubMed ID: 1530322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transarterial immuno-chemotherapy including adoptive transfer of autologous cultured lymphocytes for stage IV breast cancer patients with locally-advanced tumor].
    Kan N; Harada T; Kodama H; Ichinose Y; Moriguchi Y; Sugie T; Li L; Sato K; Imamura M
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1593-6. PubMed ID: 8373227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
    Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapleural adaptive immunotherapy for breast cancer patients with cytologically-confirmed malignant pleural effusions: an analysis of 67 patients in Kyoto and Shiga Prefecture, Japan.
    Kan N; Kodama H; Hori T; Takenaka A; Yasumura T; Kato H; Ogawa H; Mukaihara S; Kudo T; Ohsumi K
    Breast Cancer Res Treat; 1993 Sep; 27(3):203-10. PubMed ID: 8312578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer.
    Kasahara K; Shibata K; Shintani H; Iwasa K; Sone T; Kimura H; Nobata K; Hirose T; Yoshimi Y; Katayama N; Ishiura Y; Kita T; Nishi K; Nakatsumi Y; Ryoma Y; Fujimura M; Nakao S
    Anticancer Res; 2006; 26(2B):1495-9. PubMed ID: 16619563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adoptive immunotherapy of malignant pleural effusion with TIL/rIL2 (tumor-infiltrating lymphocytes/recombinant interleukin 2)].
    Han B; Jia Y; Zhou M
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Apr; 18(2):91-3, 128. PubMed ID: 7553959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of long-term (5-year) survival in patients with metastatic breast cancer to the liver].
    Kan N
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1780-4. PubMed ID: 17212106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of lymphocytes in malignant pleural effusion on the therapeutic efficacy of intrapleural OK-432 in lung cancer patients.
    Shimizu T; Takahashi N; Terakado M; Akusawa H; Tsujino I; Horie T
    Intern Med; 2006; 45(11):715-20. PubMed ID: 16819251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of T-cell receptor V beta gene usage of cytotoxic T cells induced by intrapleural administration of a streptococcal preparation, OK432, in malignant effusions.
    Miyahara E; Yamaguchi Y; Hihara J; Noma K; Toge T
    J Exp Ther Oncol; 1996 Jul; 1(4):242-50. PubMed ID: 9414411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two patients of recurrent breast cancer with carcinomatous pleurisy well controlled pleural effusion].
    Hojo S; Maeura Y; Fukunaga H; Yoshioka S; Ota H; Endo W; Yamazaki K
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1795-7. PubMed ID: 16315944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Loco-regional immunotherapy with OK-432 and cultured autologous lymphocytes for patients with metastatic cancer].
    Kan N; Imamura M
    Hum Cell; 1993 Jun; 6(2):100-5. PubMed ID: 8217947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of pleural effusion caused by lung carcinoma with circular intrapleural hyperthermic perfusion and its mechanism].
    Kang M; Zhou L; Lin P
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1176-9. PubMed ID: 11769704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of treatment with transfer of autologous or allogenic LAK cells combined with rIL-2 in 121 patients with malignant pleural effusion].
    Liu X
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):205-8. PubMed ID: 8261867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion].
    Kawaoka T; Yoshino S; Hazama S; Tangoku A; Oka M
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1562-5. PubMed ID: 14619464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [T cell receptor V beta repertoire of locoregional lymphocytes in malignant effusions].
    Miyahara E; Yamaguchi Y; Hihara J; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1622-5. PubMed ID: 7574776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect].
    Kan N; Okino T; Nakanishi M; Sato K; Mise K; Teramura Y; Yamasaki S; Hori T; Ohgaki K; Tobe T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1455-61. PubMed ID: 2786379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.